Francesco Pantano

Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan

Chiara Cremolini, Daniele Rossini, Emanuela Dell’Aquila et al. · JAMA Oncology · 2018 · 420 citations · Full text

Medicine, Oncology, Pharmacology +17

Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis

Francesca Romana Bertani, Pamela Mozetic, Marco Fioramonti et al. · Scientific Reports · 2017 · 234 citations · Full text

Life Sciences, Cell Biology, Immunology +17

miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis–Associated Genes

Martine Croset, Francesco Pantano, Casina W.S. Kan et al. · Cancer Research · 2018 · 194 citations · Full text

Medicine, Cancer Biology, Oncology +14

Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients

Daniele Santini, Gaia Schiavon, Bruno Vincenzi et al. · PLoS ONE · 2011 · 181 citations · Full text

Medicine, Cancer Biology, Oncology +17

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

Alessandro Russo, Marco Russano, Tindara Franchina et al. · Advances in Therapy · 2020 · 168 citations

Medicine, Immunology, Oncology +17